Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Licht Receives $6.25 Million Grant for Blood Cancer Research
Uncategorized

Licht Receives $6.25 Million Grant for Blood Cancer Research

By medwebOct 9, 2012
Share
Facebook Twitter Email
With his grant, Jonathan Licht, MD, and his team will work together to discover how mutant epigenetic proteins cause blood cancers.

Jonathan Licht, MD, Johanna Dobe Professor and chief of hematology and medical oncology, is one of four researchers recently awarded a grant from the Leukemia & Lymphoma Society (LLS) through its Marshall A. Lichtman Specialized Center of Research (SCOR). Licht’s grant totals $6.25 million over five years.

The SCOR program funds teams of researchers representing different disciplines who are engaged in collaborative efforts to discover new approaches to treat patients with hematological malignancies.

Along with a distinguished group of co-investigators at Rockefeller University, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, and the University of Michigan, Licht studies aberrant epigenetic regulation in leukemia, lymphoma, and myeloma.

“Our goal is to have a deeper understanding of how the genes are turned on and off by epigenetic, how mutations that occur in blood cancers can lead to patterns of abnormal gene regulation, and how therapeutic agents might be able to reverse those problems,” Licht said.

His research group includes leukemia biologists, molecular biologists, structural biologists, and chemists. The team will work together to discover how mutant epigenetic proteins cause blood cancers, develop animal models of these processes, solve the atomic structure of the proteins, and begin to develop therapies to reverse the abnormalities.

“Our group of scientists is in a position to thoroughly dissect clinical syndromes associated with acquired mutations in critical gene regulatory proteins and ask, ‘What does this protein normally do? What happens when it’s mutated? Can we reverse the process?’” he said.

Over the past five years, the group has published several papers in high impact journals such as Blood and Cancer Cell.

Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Comments are closed.

Latest News

Student Spearheads Ukraine Aid Efforts

Jun 27, 2022

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
pride7
pride6
pride5
pride4
pride3
pride2
pride1
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.